ITRM920223A1 - Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. - Google Patents

Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.

Info

Publication number
ITRM920223A1
ITRM920223A1 IT000223A ITRM920223A ITRM920223A1 IT RM920223 A1 ITRM920223 A1 IT RM920223A1 IT 000223 A IT000223 A IT 000223A IT RM920223 A ITRM920223 A IT RM920223A IT RM920223 A1 ITRM920223 A1 IT RM920223A1
Authority
IT
Italy
Prior art keywords
antibodies
idiotypic monoclonal
monoclonal antibodies
direct against
tnf
Prior art date
Application number
IT000223A
Other languages
English (en)
Inventor
Angelo Corti
Original Assignee
Mini Ricerca Scient Tecnolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mini Ricerca Scient Tecnolog filed Critical Mini Ricerca Scient Tecnolog
Priority to ITRM920223A priority Critical patent/IT1254315B/it
Publication of ITRM920223A0 publication Critical patent/ITRM920223A0/it
Priority to EP19930830121 priority patent/EP0568500A1/en
Publication of ITRM920223A1 publication Critical patent/ITRM920223A1/it
Application granted granted Critical
Publication of IT1254315B publication Critical patent/IT1254315B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ITRM920223A 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf. IT1254315B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITRM920223A IT1254315B (it) 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
EP19930830121 EP0568500A1 (en) 1992-03-27 1993-03-26 Anti-idiotype monoclonal antibodies directed against anti-TNF antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920223A IT1254315B (it) 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.

Publications (3)

Publication Number Publication Date
ITRM920223A0 ITRM920223A0 (it) 1992-03-27
ITRM920223A1 true ITRM920223A1 (it) 1993-09-27
IT1254315B IT1254315B (it) 1995-09-14

Family

ID=11400882

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920223A IT1254315B (it) 1992-03-27 1992-03-27 Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.

Country Status (2)

Country Link
EP (1) EP0568500A1 (it)
IT (1) IT1254315B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9225448D0 (en) * 1992-12-04 1993-01-27 Erba Carlo Spa Improved synthesis of polymer bioactive conjugates
AT409086B (de) * 1999-11-16 2002-05-27 Igeneon Krebs Immuntherapie Neue verwendung von antikörpern als impfstoffe
MX2010002269A (es) 2007-08-28 2010-03-25 Abbott Biotech Ltd Composiciones y metodos que comprenden proteinas de union para adalimumab.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429484A1 (en) * 1988-07-26 1991-06-05 VERIGEN, INC. (a Corporation of Delaware) Porcine polyclonal and monoclonal antibodies
WO1992003145A1 (en) * 1990-08-27 1992-03-05 Peptide Technology Ltd. Method of treating viral infection
GB9028123D0 (en) * 1990-12-28 1991-02-13 Erba Carlo Spa Monoclonal antibodies against human tumor necrosis factor alpha
CA2736076A1 (en) * 1991-03-18 1992-09-19 New York University Monoclonal and chimeric antibodies specific for human tumor necrosis factor
DE69232586T2 (de) * 1991-07-05 2002-11-28 Peptech Ltd Giftigkeit von tnf und lps ausschaltende peptide
EP0525570A3 (en) * 1991-07-31 1993-10-06 Miles Inc. Anti-idiotypic antibodies that mimic tnf

Also Published As

Publication number Publication date
ITRM920223A0 (it) 1992-03-27
EP0568500A1 (en) 1993-11-03
IT1254315B (it) 1995-09-14

Similar Documents

Publication Publication Date Title
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
DE68914244D1 (de) Monoklonaler Antikörper.
NO955167D0 (no) Monoklonalt anti-
DK145493D0 (da) Antistof
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE3885355D1 (de) Monoklonale Antikörper.
ITRM920457A0 (it) Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteinaumana.
EP0578515A3 (en) Humanized monoclonal antibodies.
FI915453A (fi) Anordning foer straenggjutning av koppar.
DE69738312D1 (de) Hepatitis b monoklonale antikörper
TR199501542A2 (tr) Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
IT8721163A0 (it) Anticorpi monoclonali contro flagelli di pseudomonas aeruginosa.
ITRM920223A1 (it) Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO873488L (no) Monoklonale antistoffer.
NO890116L (no) Monoklonale antistoffer.
ITMI910491A0 (it) Immonotossina da anticorpi monoclonali anti-cds
DE69023717D1 (de) Monoklonaler Antikörper.
FI893928A (fi) Monoklonala motkroppar.
DK370089D0 (da) Anti-urokinase monoklonale antistoffer
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
DE3787416D1 (de) Monoklonaler Antikörper gegen Laforakörper.
DE68916088D1 (de) Anti-CPBII-monoklonaler Antikörper.
NO985281D0 (no) Monoklonalt antihumant MP52-antistoff